Paydirt
EL
Insider

Elizabeth Yeu Lin

Chief Medical Officer

Elizabeth Yeu Lin (Chief Medical Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Tarsus Pharmaceuticals, Inc. (TARS). The largest single filing was $1.2M of TARS (13,953 sh across 4 lots, as filed), executed Sep 4.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.3M
shares × price, as filed
Last traded
Sep 4
Filed Sep 9

Median ADV $68.4M across their filed names

Open performance→
Volume by month
$2.1M$1.1M$0Oct 2024Apr 2025Oct 2025Apr 2026Dec 2025 · sells $165KSep 2026 · sells $2.1M
Buys $0 Sells $2.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names
TARS Tarsus Pharmaceuticals, Inc. TARS · 0 buys · 3 sells 3 filings
Recent filings
TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $1.2M
13,953 sh across 4 lots
Exec Sep 4
Filed Sep 9 · 4:13 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $898K
11,578 sh across 3 lots
Exec Sep 1
Filed Sep 3 · 4:29 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $165K
2,078 sh × $79.50
Exec Dec 16 2025
Filed Dec 17 2025 · 5:30 PM ET